Education
About Us
Working with TipRanks
Follow Us
Nuo Therapeutics (AURX)
OTHER OTC:AURX
| Dec 24 | Dec 23 | Dec 22 | Mar 22 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.37M | $ 608.52K | $ 112.25K | $ 0.00 | $ 0.00 |
| Gross Profit | $ 1.06M | $ 482.43K | $ 93.04K | $ 0.00 | $ 0.00 |
| Operating Income | $ -2.46M | $ -3.17M | $ -3.32M | $ -90.67K | $ -378.06K |
| EBITDA | $ -2.36M | $ -3.06M | $ -3.10M | $ 0.00 | $ -288.20K |
| Net Income | $ -2.32M | $ -3.17M | $ -3.03M | $ -90.67K | $ -139.26K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 283.71K | $ 928.68K | $ 2.05M | $ 148.43K | $ 151.59K |
| Total Assets | $ 1.19M | $ 1.88M | $ 3.05M | $ 149.93K | $ 153.09K |
| Total Debt | $ 164.21K | $ 255.59K | $ 335.05K | $ 0.00 | $ 0.00 |
| Net Debt | $ -119.51K | $ -673.09K | $ -1.72M | $ -148.43K | $ -151.59K |
| Total Liabilities | $ 675.80K | $ 838.73K | $ 856.02K | $ 672.47K | $ 668.87K |
| Stockholders' Equity | $ 513.71K | $ 1.04M | $ 2.19M | $ -522.54K | $ -515.79K |
| Cash Flow | |||||
| Free Cash Flow | $ -2.39M | $ -3.18M | $ -3.77M | $ -13.00K | $ -9.85K |
| Operating Cash Flow | $ -2.23M | $ -3.17M | $ -3.71M | $ -13.00K | $ -9.85K |
| Investing Cash Flow | $ -154.96K | $ -7.24K | $ -59.99K | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 1.74M | $ 2.00M | $ 4.46M | $ 1.37T | $ 195.00K |
Nuo Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.